Resultados de la búsqueda 251-260 of 6560 for Root+canal+treatment

  1. Clinical Update - December 2008 - MC2024-1208

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ...

  3. Clinical Update - July 2009 - MC2024-0709

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  4. Cirugía ortopédica - Ensayos clínicos - Mayo Clinic

    For each age group, two to three common treatment regimens currently used by practicing pediatric orthopaedic surgeons will be compared. The intervention a ...

  5. Mayo Clinic Surgery Physician Update - June 2025

    Page 1.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to evaluate the utility, safety, effectiveness, and cost of physical therapy on elective spine surgery patients.

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

  9. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...